Download Curriculum Vitae - Vanderbilt University School of Medicine

CURRICULUM VITAE
Ban Mishu Allos, M.D.
Address
Division of Infectious Diseases
A-2200 Medical Center North
Vanderbilt University School of Medicine
Nashville, TN 37232
Telephone
Fax
e-mail
(615) 322-2035
(615) 343-6160
[email protected]
Education
1977-1981
College: Emory University, Atlanta, GA
Degree: B.A.
Majors: American History, Chemistry
1981-1985
Medical School: University of Tennessee College of Medicine,
Memphis, TN
Degree: M.D.
1985-1988
Residency: Internal Medicine
Loyola University School of Medicine, Chicago, IL
1988-1990
Epidemic Intelligence Service Officer
Division of Field Services, assigned to Tennessee Dept. of Health
Centers for Disease Control, Atlanta, GA
1989-1991
Residency: Preventive Medicine
Enteric Diseases Branch, Bacterial Diseases Division
Centers for Disease Control, Atlanta, GA
1991-1993
Fellowship: Infectious Diseases
Vanderbilt University School of Medicine, Nashville, TN
Uniformed Services:
Commissioned Officer, Lieutenant Commander
United States Public Health Service, 1988-1991
Licensure and
Board Certifications:
American Board of Internal Medicine, Internal Medicine, 1989
American Board of Internal Medicine, Infectious Diseases, 1996.
Recertified, 2005
Illinois: 1985-1990
Tennessee: 1990-present
Academic appointments:
Assistant Professor, Division of Infectious Diseases, Department
1
of Medicine
Assistant Professor, Department of Preventive Medicine
Vanderbilt University School of Medicine
Hospital appointments
Divisional Compliance Expert (DCE), member 2001-present
Chair, 2010- present
Awards and honors:
National
Public Health Service Commissioned Officer Award, 1988
U.S. Public Health Service Citation, 1989, 1991
President, International Campylobacter Society, 1996-1998
Guest editor, Development of Guillain-Barre syndrome following
Campylobacter infection. Journal of Infectious Diseases
1997;176:S91-S200.
Guest editor, FoodNet and Surveillance of Foodborne Disease in
the United States. Clin Infect Dis 2004;38 Suppl 3:S115-317.
Local:
John S. Sergent Award for Excellence in Teaching (Small Group
Setting) (2007-2008)
Member, Academy for Excellence in Teaching – 2008- present
Professional organizations:
Member, Infectious Diseases Society of Tennessee
Member, American Society for Microbiology 1994-2000
Member, Infectious Diseases Society of America (IDSA)
Professional activities:
Intramural:
Division of Infectious Diseases Fellowship, Director: 1998-2004
Institutional Review Board Subcommittee, member: 1999- 2009
Institutional Review Board Subcommittee, vice-chair: 2002-2007
Dept of Medicine, Divisional Compliance Expert (DCE)
Member. 2000 –present
Chair, 2010-present
ID Fellowship Selection Committee, member: 1998-present
Medical School Admissions Screener, 2004-2011
Medical School Admissions Committee 2011- present
Progress and Promotions Committee, 2005-2009
Medical School Curriculum Committee, 2006- 2008, 2010-present
American Medical Women’s Association, mentor, 2005 – present
Medical School Student advisor, 1995-2007
Medical School College Mentor, Gabbe College, 2007-present
2
School of Medicine Faculty Advisory Council, 2007-2009
Extramural:
International Campylobacter Society, President, 1996-1998
Infectious Diseases Society of America (IDSA) Public Policy
committee, member, 2001-2004
CDC’s Advisory Committee for Immunization Practices, member,
2003-2007
CDC’s Advisory Committee for Immunization Practices, Chair of
the Influenza Working Group 2003-2007
USMLE part 1, Pathology test item writer 2008- 2010
Editorial responsibilities
Journal reviewer:
American Journal of Epidemiology
American Journal of Medicine
American Journal of Public Health
Annals of Internal Medicine
Annals of Neurology
Antimicrobial Agents and Chemotherapy
Clinical Infectious Diseases
European J of Clinical Microbiology and Infectious Diseases
Infection Control and Hospital Epidemiology
Infection and Immunity
International Journal of Epidemiology
Journal of the American Medical Association
Journal of Endotoxin Research
Journal of Infectious Diseases
Journal of Neurology, Neurosurgery, and Psychiatry
Western Journal of Medicine
Grant Reviewer:
U.S. Centers for Disease Control and Prevention
Guest Editor:
Development
of
Guillain-Barre
Campylobacter infection. Journal
1997;176:S91-S200.
syndrome
of Infectious
following
Diseases
Studies of Foodborne Infectious Diseases in the United States.
Findings from the Foodborne Diseases Active Surveillance
Network (FoodNet) of the Emerging Infections Program. Clin
Infect Dis 2004;38 Suppl 3:S115-317
Teaching activities
Medical school courses:
2001-present Section director, Medical students’, first year microbiology course
(bacteriology)
3
1994-2008
Annual lectures on outbreaks of tuberculosis, hepatitis A, in Preventive
Medicine course
1995-present Microbial Topic small group leader
2005-present: Course director, Capstone course (required, fourth year medical school
course)
2008-2010
Foundations of the Profession small group leader
2009- present: Annual lectures in DD&T course on UTI, acute infectious diarrhea
2010-present Section director, DD&T (Antimicrobial agents)
2010-present Colloquium in Medicine
Clinical teaching
Regularly supervise residents and fellows on the ID consult service and in the ID clinic
Research teaching
Regularly participate as a member of fellows’ mentoring committees.
Extramural activities
Preceptor for AIDS Outreach Program 1998-1999 (organized and trained medical
students to teach area middle and high school students about AIDS prevention)
Civic and political activities
Testified about the association between C. jejuni infection and GBS in front of a U.S.
Congressional Subcommittee, Washington D.C., 1996.
Invited Lectures
Interscience Conference on Antimicrobial Agents and Chemotherapy. 29th meeting, Houston,
TX, September 1989.
Epidemic Intelligence Service Conference, Centers for Disease Control.
1990.
Atlanta, GA, April
International AIDS Conference, San Francisco, CA, June 1990.
National Institutes of Health Symposium on Guillain-Barre syndrome, Bethesda, MD, June
1991.
American Society of Tropical Medicine and Hygiene, Boston, MA, April 1991.
American Society of Microbiology, 91st Annual Meeting, Dallas, TX, May 1991.
Infectious Diseases Society of America, Annaheim, CA, October 1992.
Interscience Conference on Antimicrobial Agents and Chemotherapy, 32nd meeting, Annaheim,
CA October 1992.
4
University of Tennessee College of Medicine, Memphis, TN, March 1992, 1993.
National Institutes of Health (National Institute of Neurologic Diseases and Stroke) International
Symposium on GBS and Guillain-Barre-like syndromes, Wurzburg, Germany, February
1993.
American Society for Microbiology. 93rd Annual Meeting, Atlanta, GA, May 1993.
International Workshop on Campylobacter, Helicobacter, and Related Organisms, VIIth annual
meeting, Brussels, Belgium September 1993.
Infectious Diseases Society of America, New Orleans, LA October 1993.
Interscience Conference on Antimicrobial Agents and Chemotherapy, 33rd meeting,
Orleans, LA, October 1993.
New
American Gastroenterologic Association, Annual Meeting, Boston, MA, October 1993.
Medical Surgical Grand Rounds. Grant Hospital. Cincinnati, Ohio, January 1994.
American Society of Microbiology, 94th Annual Meeting, Las Vegas, NV, May 1994.
National Institutes of Health, Bethesda, MD, August 1994.
Infectious Diseases Society of America, Orlando, FL, September 1994.
American Society of Microbiology, 95th Annual Meeting, Washington D.C., May 1995.
Campylobacter, Helicobacter, and related organisms, VIIIth International Meeting, Winchester,
England, July 1995.
National Institutes of Health. Symposium on Campylobacter and the Guillain-Barre syndrome.
Bethesda, MD, August 1996.
American Society of Microbiology, Philadelphia Chapter, Philadelphia PA, December 1997.
American Society of Microbiology, 97th Annual Meeting, Miami, FL, May 1997.
Annual Meeting of the Infectious Diseases Society of Tennessee, Nashville, TN, September
1997.
Tennessee Public Health Conference III. Gatlinburg, TN. September 1998.
Infectious Diseases Society of America.
November 1998.
Invited Plenary Session Speaker.
Denver, CO.
Workshop on Campylobacter, Helicobacter, and related organisms. Xth International Workshop,
Plenary Session Chair. Baltimore, MD. August 1999.
5
American Society of Microbiology, 100th Annual Meeting, Los Angeles, CA, May 2000.
Intl Assn for Food Protection. 94th Annual Meeting, Orlando, FL. July 2007. Invited speaker.
American Association of Medical Colleges, Learning Communities Institute Meeting, Innovations
and Dilemmas in Medical School Learning Communities, Denver, CO, November 2011
Grant awards
Award title:
Muscular Dystrophy Association Fellowship Award
Funding agency: Muscular Dystrophy Association
Project title:
Association of Campylobacter infection and GBS
Role in project: Principal investigator
Dates: 1992-1994
Budget: $53,000 (direct costs)
Award title:
K08-NS01709 (Clinical Investigator Award)
Funding agency: National Institutes of Health
Project title: Campylobacter jejuni as a cause GBS
Role in project Principal investigator
Dates: 1993-1998
Budget: $360,777 (direct costs)
Award Title: Emerging Infectious Diseases Program Grant
Funding agency: Centers for Disease Control and Prevention
Project title: Campylobacter infection and the Guillain-Barre
Syndrome
Role in project: Principal investigator (of sub-project)
Dates: 1999-2004
Budget: $1,024,294 (sub-project direct costs)
PUBLICATIONS
Reviewed Contributions
1.
Mishu B, Hadler SC, Boaz VA, Hutcheson RH, Horan JM, Schaffner W. Foodborne
hepatitis A: Evidence that microwaving reduces risk? J Infect Dis 1990;162:655-658.
2.
Mishu B, Schaffner W, Horan JM, Wood LH, Hutcheson RH, McNabb PC. A surgeon
with AIDS: lack of evidence of transmission to patients. JAMA 1990;264:467-470.
3.
Mishu B, Griffin PM, Tauxe RV, Cameron DN, Hutcheson RH, Schaffner W. Salmonella
enteritidis gastroenteritis transmitted by intact eggs: the epidemic advances. Ann Intern
Med 1991;115:190-194.
4.
Weber JT, Hibbs RG, Darwish A, Mishu B, Corwin AL, Rakha M, Hatheway CL,
6
Sharkawy SE, El-Rahim AS, Sheba MF, Sarn JE, Blake PA, Tauxe RV. A massive
outbreak of type E botulism in Cairo, Egypt. J Infect Dis 1993;167:451-454.
5.
Vugia DJ, Mishu B, Smith M, Tavris DR, Hickman-Brenner FW, Tauxe RV. Salmonella
enteritidis outbreak in a restaurant chain: the continuing challenges of prevention.
Epidemiol Infect 1993;110:49-61.
6.
McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z, Zhaori G, Liu Y, Jou
LP, Liu TC, Gao CY, Mao JY, Blaser MJ, Mishu B, Asbury AK. Acute motor axonal
neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol
1993;33:333-342.
7.
Mishu B, Amjad AA, Koski CL, Vriesendorp F, Cook SA, Mithen F, Blaser MJ. Serologic
evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barre
Syndrome. Ann Intern Med 1993;118:947-953.
8.
Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL. Serum antibodies to GM1, Gd1b,
peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barre
syndrome and controls: correlation and prognosis. Ann Neurol 1993;34:130-135.
9.
Mishu B, Blaser MJ. The role of Campylobacter jejuni infection in the initiation of
Guillain-Barre Syndrome. Clin Infect Dis 1993;17:104-108.
10.
Mishu B, Koehler J, Lee LA, Rodrigue D, Brenner F, Blake P, Tauxe RV. Outbreaks of
Salmonella enteritidis infections in the United States, 1985-1991.
J Infect Dis
1994;169:547-52.
11.
Marrie TJ, Purdy RA, Johnston BL, McCormick CW, Benstead T, Ansell J, Maloney W,
Allos BM, Blaser MJ. Encephalomyeloradiculopathy of infectious or parainfectious
etiology - a new entity? J Infect Dis 1995;20:945-953.
12.
Griffin JW, Li CY, Ho TW, Xue P, Macko C, Gao CY, Yang C, Tian M, Mishu B,
Cornblath DR, McKhann GM, Asbury AK. Guillain-Barre syndrome in Northern China:
the spectrum of neuropathologic changes in clinically defined cases.
Brain
1995;118:577-595.
13.
Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, Asbury AK, Blaser MJ,
McKhann GM.
Guillain-Barre syndrome in northern China: relationship to
Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605.
14.
Griffin JW, Li CY, Ho TW, Tian M, Gao CY, Xue P, Mishu B, Cornblath DR, Macko C,
McKhann GM, Asbury AK. Pathology of motor-sensory axonal Guillain-Barre syndrome.
Ann Neurol 1996;39:17-28.
15.
Hibbs RG, Weber JT, Corwin C, Allos BM, Abd el Rehim MS, Sharkawy S, , Sarn JE,
McKee KT. Experience with the use of an investigational F(ab')2 heptavalent botulism
immune globulin of equine origin during an outbreak of type E botulism in Egypt. Clin
Infect Dis 1996;23:337-40.
7
16.
Allos BM, Gensheimer KF, Bloch AB, Horan JM, Schaffner W. Spread of tuberculosis
in a small community: public health implications. Ann Intern Med 1996;125:114-117.
17.
Fujimoto S, Allos BM, Patton CM, Blaser MJB.
Restriction fragment length
polymorphism analysis and random amplified polymorphic DNA analysis of
Campylobacter jejuni strains isolated from patient with Guillain-Barre syndrome. J
Infect Dis 1997;176:1105-1108.
18.
Allos BM. Campylobacter jejuni infection and the Guillain-Barre syndrome. Specialist
Medicine 1997;19;60-64.
19.
Busby TC, Allos BM, Roberts T. Economic costs of C. jejuni -associated Guillain-Barre
syndrome. J Infect Dis 1997;(Suppl 2):S192-197.
20.
Allos BM. Evidence of an association between Campylobacter jejuni infection and
Guillain-Barre syndrome. J Infect Dis 1997;(Suppl 2):S125-128.
21.
Misawa N, Allos BM, Blaser MJ. Differentiation of Campylobacter jejuni strains of
serotype O:19 from non-O:19 strains by polymerase chain reaction. J Clin Microbiol
1998;36:3567-3573.
22.
Allos BM, Lippy FE, Carlsen AR, Blaser MJ. Serotype, serum resistance and 125I-C3
binding among C. jejuni strains from patients with Guillain-Barre syndrome or with
uncomplicated enteritis. Emerging Infectious Diseases 1998;4:263-268.
23.
Nachamkin I, Allos BM. Ho T. Campylobacter jejuni infection and the Guillain-Barre
syndrome. Clinical Microbiology Reviews 1998;11:555-567.
24.
Allos BM. Campylobacter jejuni infection as a cause of the Guillain-Barre syndrome.
Infect Dis Clinics N America. March 1998;12:173-184.
25.
Misawa N, Kawashima K, Kondo F, Allos BM, Blaser MJ. DNA diversity of the wla gene
cluster among serotype HS:19 and non-HS:19 Campylobacter jejuni strains. J Endotox
Research 2001;7:1-10.
26.
Allos BM. Postexposure prophylaxis of healthcare personnel exposed to HIV. Current
Treatment Options Infect Dis 2002;4:57-65.
Chapters, Reviews, and Invited Contributions
1.
Mishu B, Tauxe RV, Patton C. Clinical and epidemiologic features of non-jejuni
Campylobacters. In: Nachamkin I, Blaser MJ, Tompkins LS, eds. Campylobacter jejuni -current strategy and future trends. Washington D.C., American Society of Microbiology;
1992:31-41.
2.
Mishu B. Rabies: A primer for the practicing physician. Infectious Disease Newsletter
1993;12:1-4.
8
3.
Dummer JS, Allos BM. Gastrointestinal infections in transplant recipients. In: Blaser
MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, eds. Infections of the
Gastrointestinal Tract. New York, Raven Press; 1995:511-526.
4.
Allos BM, Lastovica A, Blaser MJ. Atypical Campylobacters and related organisms. In:
Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, eds. Infections of the
Gastrointestinal Tract. New York, Raven Press; 1995:849-866.
5.
Mishu B, Tauxe RV, Griffin PM, Blaser MJ. Campylobacter jejuni infection and the
Guillain Barre Syndrome. In: Gibbs CJ, McKhann GM, eds. New Issues in
Neurosciences: Basic and Clinical Approaches. Bethesda, National Institutes of Health,
1992/1993; 268-271.
6.
Allos BM, Blaser MJ. Campylobacter jejuni and the expanding spectrum of related
infections. Clin Infect Dis 1995;20:1092-1101.
7.
Schaffner W, Allos BM. Protecting patients when their surgeon or dentist is infected
with a blood-borne virus. J Hosp Infect 1995;30(Suppl):156-162.
8.
Allos BM, Blaser MJ. Potential role of lipopolysaccharides of Campylobacter jejuni in
the development of Guillain-Barre syndrome. J Endotoxin Res 1995;2:237-238.
9.
Busby JC, Roberts T, Allos BM. Estimated Annual Costs of Campylobacter-associated
Guillain-Barre syndrome.
Economic Research Services Report, United States
Department of Agriculture, Washington D.C, 1997.
10.
Allos BM. Campylobacter jejuni. In: Gorbach SL, Bartlett JG, Blacklow NR, eds.
Infectious Diseases (second edition). Philadelphia, WB Saunders Company; 1998:726732.
11.
Allos BM. Campylobacter. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious
Diseases (second edition). Philadelphia, WB Saunders Company; 1998:1810-1815.
12.
Allos BM, Taylor DN. Campylobacter infections. In: Evans AS, Brachman PS, eds.
Bacterial Infections of Humans: Epidemiology and Control. New York, Plenum Medical
Book Company, 1998:169-190.
13.
Allos BM, Blaser MJ. Campylobacter species. In: Yu VL, Merigan T, Barriere SL, eds.
Antimicrobial Therapy and Vaccines. Baltimore, Williams and Wilkins, 1998:101-109.
14.
Allos BM, Blaser MJ. Campylobacter infections in the developing world. In: Guerrant
RL, Walker DH, Weller PF, eds. Tropical Infectious Diseases. Philadelphia, Churchill
Livingstone, 1999:319-325.
15.
Nachamkin I, Allos BM. Ho T. Campylobacter jejuni infection and the association with
Guillain-Barre syndrome. In: Nachamkin I, Blaser MJ (eds). Campylobacter (second
edition). Washington DC, ASM Press, 2000: 155-175.
9
16.
Allos BM. Campylobacter jejuni infections: update on emerging issues and trends. Clin
Infect Dis 2001;32:1201-1206.
17.
Allos BM, Blaser MJ. Campylobacter species. In Yu, Weber, Raoult, eds.
Antimicrobial Therapy and Vaccines (second edition). New York, Apple Trees
Productions, LLC, 2002: 169-171.
18.
Allos BM. Moore MR. Griffin PM. Tauxe RV. Surveillance for sporadic foodborne
disease in the 21st century: the FoodNet perspective. Clin Infect Dis 2004;38 Suppl
3:S115-120
19
Lastovica AJ, Allos BM. Clinical significance of Campylobacter and related
species other than Campylobacter jejuni and Campylobacter coli. In: Nachamkin I,
Szymanski CM, Blaser MJ (eds). Campylobacter (third edition). Washington DC, ASM
Press, 2008: 123-150.
20
Allos BM, Blaser MJ. Campylobacter jejuni. In: Cecils Textbook of Medicine; 23rd ed.
B Saunders Co., 2008 2231-2233.
21.
Allos BM, Blaser MJ. Campylobacter jejuni and related species. In: Mandell (GL),
Bennett JE, Dolin R (eds) Mandell, Douglas and Bennett’s Principles and Practice of
Infectious Diseases., 7th ed. Philadelphia: Churchhill Livingstone; 2010; 2793-2802.
22.
Allos BM. Campylobacter: clinical characteristics. In: UpToDate®, Inc.
founded by Burton D. Rose, MD & Joseph M. Rush, M, 2010.
23.
Allos BM. Campylobacter: microbiology and epidemiology. In: UpToDate®, Inc.
founded by Burton D. Rose, MD & Joseph M. Rush, M, 2010
Editorials
1.
Mishu B, Schaffner W. HIV-infected surgeons and dentists: looking back and looking
forward. JAMA 1993;269:1843-1844.
2.
Mishu B, Schaffner W. HIV transmission from surgeons to patients: Can models predict
magnitude of risk? Infect Control Hosp Epidemiol 1994;15:144-147.
3.
Mishu B, Blaser MJ. Do you have a Campylobacter in your future? West J Med
1994;161:186-187.
4.
Allos BM, Blaser MJ. Campylobacter jejuni Infection and the Guillain-Barre Syndrome:
Mechanisms and Implications. International Journal of Medical Microbiology, Virology,
Paristology, and Infectious Diseases 1994;281:544-548.
10
5.
Lang DA, Allos BM, Blaser MJ(guest editors). Development of Guillain-Barre Syndrome
following Campylobacter Infection. J Infect Dis 1997;176:S91.
6.
Allos BM, Schaffner. Patient to patient transmission of hepatitis B: An elephant in the
room ….. or a mouse? J Infect Dis 2007;195:1311-1314
Letters and other Contributions
1.
False-positive Mono-spot tests in East Tennessee. Tennessee Communicable Diseases
Bulletin 1989.
2.
Salmonella enteritidis infections and shell eggs - United States, 1990. MMWR
1990;39:909-12
3.
Campylobacter enteritis - New Zealand 1990. Editorial Note. MMWR 1991;40:123.
4.
Mishu B, Schaffner W. A surgeon with AIDS. (letter) JAMA 1991;264:3147-8.
5.
Mishu B, Schaffner W. Foodborne hepatitis A and microwaves.(letter) J Infect Dis
1991;163:918.
6.
Mishu B, Griffin PM, Schaffner, W. Eggs and Salmonella enteritidis transmission.
(letter) Ann Intern Med 1992;116:93-94.
7.
Mishu B, Griffin PM.
Correction: Gastroenteritis transmitted by intact chicken
eggs.(letter) Ann Intern Med 1992;116:1037.
8.
Mishu B, Blaser MJ. Campylobacter jejuni infection, Guillain-Barre Syndrome and
Human Immunodeficiency Virus infection. (letter) J Infect Dis 1994;169:1177.
9.
Allos BM. Reply. (Letter) Clinical Infect Dis 2002;34:720-721.
11